Core Viewpoint - The chairman of iFlytek, Liu Qingfeng, highlighted the challenges of conducting large model training and algorithm innovation based on domestic computing power, emphasizing the need for additional steps and computational resources [1] Group 1: Domestic Computing Power Challenges - Liu Qingfeng pointed out that developing new algorithms based on domestic computing power will be three months slower compared to using overseas computing power [1] - The company insists on self-controllability as a necessary choice to avoid being constrained by external factors [1]

Core Viewpoint - The company, as a leader in the domestic scientific instrument industry, is facing significant development opportunities under the national push for self-control and domestic substitution. With the deepening of relevant support policies and the gradual release of equipment renewal demand in downstream industries, the company is expected to achieve rapid growth in order acquisition and revenue conversion in the scientific instrument field by 2025 [1][5][10] Financial Performance - In 2024, the company achieved revenue of 3.614 billion yuan, a year-on-year increase of 13.58%, and a net profit attributable to shareholders of 207 million yuan, a year-on-year increase of 164.11%. The non-recurring net profit attributable to shareholders was 127 million yuan, a year-on-year increase of 132.82% [1][3] - For Q1 2025, the company reported revenue of 547 million yuan, a year-on-year increase of 1.38%, and a net profit attributable to shareholders of -21 million yuan, a year-on-year increase of 18.77% [1][4] Business Strategy - The company is focusing on core businesses such as scientific instruments, life science instruments, and industrial analysis instruments, while appropriately reducing long-term R&D layouts and non-high-end analysis instrument businesses. This strategy has led to a significant turnaround in profitability [3][10] - The company has established four business units targeting clinical research and early disease diagnosis, indicating a proactive approach to expanding into the life sciences sector [7] Operational Efficiency - The overall gross margin for 2024 was 44.43%, an increase of 3.17 percentage points year-on-year. The company has effectively controlled expenses, with a sales expense ratio of approximately 16.67%, a decrease of about 4.21 percentage points [8][9] - The net cash flow from operating activities for 2024 was 688 million yuan, a year-on-year increase of 152.34%, reflecting improved operational quality [8] Future Outlook - The company is expected to benefit from the acceleration of local government debt reduction and the gradual alleviation of the negative impact of PPP projects on overall performance. This is anticipated to support the company's performance recovery [5][6][10] - Projections for 2025-2027 indicate expected revenues of 4.066 billion, 4.538 billion, and 5.039 billion yuan, with corresponding net profits of 320 million, 439 million, and 589 million yuan, reflecting a strong growth trajectory [11]

Group 1: Strategic Emerging Industries Development - The government work report emphasizes the promotion of integrated cluster development in strategic emerging industries, highlighting the formation of substantial industrial clusters in the Sci-Tech Innovation Board [1] - The Sci-Tech Innovation Board has 113 listed companies in the biopharmaceutical sector, focusing on treatments for cancer, AIDS, and hepatitis B, making it a major listing venue globally outside the US and Hong Kong [1] - In the integrated circuit sector, there are 119 companies, representing a significant portion of A-share listed companies, with a complete industrial chain from chip design to packaging and testing [1] Group 2: Biopharmaceutical Sector Innovations - The National Medical Products Administration approved 11 new drugs, with five from Sci-Tech Innovation Board companies, indicating a strong performance in drug innovation [2] - Eight new drugs have been approved for Sci-Tech Innovation Board innovative drug companies this year, with a total of 33 globally new class 1 drugs launched since 2018, accounting for 14% of domestic approvals [2] - The medical device sector has seen increased domestic production rates for high-end imaging equipment, with companies establishing resilient supply chains [2] Group 3: Integrated Circuit Industry Growth - The integrated circuit sector reported a net profit of 4.479 billion yuan in Q1, a 73% year-on-year increase, driven by domestic substitution and demand recovery [4] - Companies in the chip design and semiconductor equipment sectors have shown significant revenue and profit growth, with some companies like Hengxuan Technology achieving a 590.22% increase in net profit [4][5] - The production capacity and order status of wafer manufacturing companies remain strong, with major players like SMIC and Huahong maintaining high utilization rates [5] Group 4: Strategic Expansion and Internationalization - Companies in the Sci-Tech Innovation Board are exploring mergers and acquisitions to achieve external growth, with recent announcements of mergers such as Haiguang Information and Zhongke Shuguang [6] - The internationalization of biopharmaceutical companies is accelerating, with 11 companies granting overseas rights to their innovative drugs, marking a significant step towards global market entry [7] - The collaboration between domestic companies and global research institutions is increasing, with over 55 top research institutions engaged in partnerships, facilitating the global transformation of innovative results [7]

截至6月9日，信创ETF易方达(159540)最新规模达7.09亿元，最新份额达5.90亿份，均创成立以来新高。 从资金净流入方面来看，信创ETF易方达(159540)近10天获得连续资金净流入，合计"吸金"5.45亿元。 联接A：020403 国产"算力"航母正式落地。6月9日晚间，海光信息披露重大资产重组预案。海光信息拟向中科曙光的全 体换股股东发行A股股票，交换该等股东所持有的中科曙光股票。吸收合并方换股价格为143.46元/股， 被吸收合并方换股价格为79.26元/股。换股吸收合并完成后，中科曙光将终止上市，海光信息将承继及 承接中科曙光的全部资产、负债、业务、人员、合同及其他一切权利与义务。 联接C：020404 关联产品： 截至2025年6月10日收盘，信创ETF易方达(159540)换手34.93%，全天成交2.33亿元，市场交投活跃。 信创ETF易方达：159540 天风证券认为，经贸协商未完待续，自主可控仍是长期逻辑。信创板块收入端稳健复苏，结构性亮点突 出，国产算力与信创板块受益于政策支持自主可控与技术迭代，景气度有望持续上行。 信创ETF易方达(159540)跟踪国证信息技术创新主题指数 ...

Group 1 - Guokemicro (300672.SZ) announced a major asset restructuring plan to acquire 94.366% of the shares of Zhongxin Integrated Circuit (Ningbo) Co., Ltd. through a combination of issuing shares and cash payments, aiming to establish a dual-driven system of "digital chip design + analog chip manufacturing" in the semiconductor field [1] - Guokemicro is a leader in the domestic integrated circuit design sector, focusing on chip design and R&D, providing solutions for AI, multimedia, automotive electronics, IoT, and data storage, with products widely used in various popular fields [1] - Zhongxin Ningbo operates primarily under a Foundry model, specializing in RF front-end and MEMS semiconductor wafer foundry and customized chip manufacturing services, equipped with 6-inch and 8-inch wafer manufacturing lines [1] Group 2 - Zhongxin Ningbo has established deep cooperation with leading domestic mobile terminal companies, signing a strategic cooperation framework agreement to supply 50% of the RF filters needed for mobile terminal products, indicating strong recognition of its products [2] - China has become the largest RF filter consumption market globally, accounting for nearly 30% of the market size, but domestic companies hold less than 5% of the BAW filter market, which is dominated by US firms like Broadcom and Qorvo [2] - With the deepening of 5G commercialization and accelerated 6G technology development, the demand for high-performance RF front-end devices is increasing, making BAW filters a critical bottleneck [2] Group 3 - The acquisition of Zhongxin Ningbo will enhance Guokemicro's production capabilities in high-end filters and MEMS, while leveraging Zhongxin Ningbo's cooperation with strategic clients to expand into markets such as smartphones and smart connected vehicles [3] - This acquisition extends Guokemicro's industrial chain layout into the high-value core components of RF front-end, enhancing competitiveness in the analog chip market and opening new business growth points [3] - The collaboration between Zhongxin Ningbo and strategic clients will inject strong momentum into the domestic filter industry, promoting the semiconductor industry chain towards self-control and technological innovation, gradually breaking the long-standing monopoly of foreign companies in the high-end filter market [3]

编 辑丨骆一帆 梁明 刘雪莹 6月9日晚间，海光信息（688041.SH）和中科曙光（603019.SH）双双公告披露换股吸收合并 预案。海光信息拟换股吸收合并中科曙光，并向特定投资者发行股份募集配套资金， 两家公 司股票将于6月10日开市起复牌。 本次合并完成后， 海光信息将承继及承接中科曙光的全部资产、负债、业务、人员及其他 一切权利与义务 ，海光信息因本次换股吸收合并所发行的A股股票将申请在上交所科创板 上市流通， 中科曙光将终止上市。 作 者丨张赛男 唐铮玮 备受关注的A股两大细分龙头的重组预案出炉。 值得注意的是， 该交易将成为5月16日《上市公司重大资产重组管理办法》正式修订发布后首 单上市公司之间吸收合并交易。 市场人士普遍认为，若相关工作顺利推进，将实现产业链相 互补充，进一步促进信息产业龙头企业发展，对信息产业格局产生较大影响。 恒泰证券指出，海光信息与中科曙光的合并，将打造从芯片到软件到硬件全产业链布局，有 助于提升国产算力整体竞争力，符合国家支持自主可控的战略方向，同时，此次并购重组是 自5月16日证监会修订发布《上市公司重大资产重组管理办法》后，首单上市公司之间吸收合 并交易，标志着中 ...

Group 1 - Several foreign institutions have raised their GDP growth forecasts for China in 2025, indicating a growing optimism towards Chinese assets [1][8][11] - Morgan Stanley, Deutsche Bank, and others have expressed bullish sentiments on Chinese stocks, with Morgan Stanley's mid-year outlook predicting increases in major indices [1][4][5] - High demand for Chinese assets is driven by a stronger RMB against the USD, improved corporate earnings outlook, and anticipated foreign capital inflows [5][6] Group 2 - Foreign institutions are focusing on two main sectors: technology and internet leaders, and high-dividend strategies to hedge against volatility [6][7] - The trend of overweighting Chinese assets has been noted, with Standard Chartered and HSBC highlighting the importance of diversifying investments in Asia [7] - Recent adjustments in GDP growth forecasts reflect a broader expectation of economic improvement, supported by policy measures and potential fiscal stimulus [8][9][11]

Investment Rating - The investment rating for the machinery equipment industry is "Recommended" [2][4][48] Core Views - The machinery industry is experiencing structural opportunities driven by policy support, technological iteration, and globalization. The recent market has shown rapid rotation of hotspots, suggesting a favorable environment for left-side layout in less crowded sectors [4][48] - The operating rate of engineering machinery has decreased, while export demand continues to recover. In May 2025, the average operating rate for major engineering machinery products was 59.5%, down 5.01 percentage points year-on-year and 2.45 percentage points month-on-month [4][49] - Domestic demand is expected to recover due to a new round of concentrated replacement cycles, the gradual effects of real estate easing policies, and the catalytic effects of national large-scale replacement policies [49] Summary by Sections Industry Performance - The machinery equipment index rose by 1.18% from June 3 to June 6, 2025, ranking 18th among 31 primary industries. Sub-industries such as laser equipment (+5.08%) and engineering machinery components (+3.46%) performed well, while textile and apparel equipment (-1.77%) and engineering machinery complete machines (-1.16%) saw declines [4][48] - In April 2025, excavator sales reached 22,142 units, a year-on-year increase of 17.6%, with domestic sales of 12,547 units (+16.4%) and exports of 9,595 units (+19.3%) [40][49] Key Data - As of May 2025, the manufacturing PMI was 49.5%, with a month-on-month increase of 0.5 percentage points. The production index and new orders index showed signs of recovery, indicating improved business expectations and operational activities [18][50] - The production of industrial robots in April 2025 was 71,547 units, a year-on-year increase of 51.5%, attributed to the "old-for-new" policy and effective loan interest subsidies for equipment upgrades [29][51] Company Focus - Companies to watch include XCMG (000425.SZ), Sany Heavy Industry (600031.SH), and Zoomlion (000157.SZ) for engineering machinery, and Huazhong CNC (300161.SZ), Neway CNC (688697.SH), and Haitian Precision (601882.SH) for general equipment [4][49][50] - The report highlights the importance of focusing on high-tech segments such as reducers and servo systems, as well as system integrators benefiting from diversified downstream applications [51]

Core Viewpoint - The A-share market is experiencing a fluctuating upward trend, with specific sectors such as CRO, weight loss drugs, and innovative pharmaceuticals showing significant gains. The rise of self-controllable technology and the acceleration of AI commercialization are driving the technology sector's performance [1][2]. Group 1: Market Performance - The A-share market maintained a fluctuating upward trend, with a slight pullback in the afternoon [1] - The CRO, weight loss drugs, and innovative pharmaceuticals sectors saw the highest gains in the afternoon [1] - The 信创 ETF (562570) rose nearly 1% at the close, with top holdings including 用友网络 (600588) and 泛微网络 (603039) [1] Group 2: Industry Trends - The computer industry has entered a new AI Agent market phase, accelerating the commercialization of technology [1] - The 信创 industry chain is undergoing mergers and acquisitions, evolving towards "technology complementary integration" and "ecosystem closure construction" [1] - Current mergers and acquisitions exhibit three main characteristics: 1) Technology collaboration orientation, where companies acquire to fill technological gaps [2] 2) Policy-driven concentration, enhancing industry concentration and encouraging mergers for resource optimization [2] 3) International ecological layout, allowing companies to acquire core technologies through cross-border mergers [2] Group 3: Related ETFs - 信创 ETF (562570) is closely related to the strategic restructuring of 海光信息 and 中科曙光, which are significant components of the index [3] - 云计算50 ETF (516630) tracks an index with a high AI computing content, covering various popular computing concepts [3] - As of May 30, 中科曙光 is the sixth largest component of the 云计算50 ETF, with a weight of 4.32% [3]

国证通用航空产业指数的军工行业占比及无人机相关公司占比均较高(军工占比60%、无人机占比56%， 数据来源：Wind，截至2025/5/30)，未来有望同时受益于两个板块的景气度提升。首先是军工方面，在 全球贸易关税政策不确定性急剧上升的背景下，各国都在加强国防军事开支，中国军用装备的海外关注 度持续提升，军贸订单有望放量。第二是低空经济方面，全球首批民用无人驾驶航空器运营合格证 (OC)落地中国，从应用场景来看，短期无人机巡检、救援、植保等场景有望加速落地，中期低空文旅 观光、无人机物流打开广阔空间，长期来看有望颠覆传统交通方式、带来未来交通出行方式的重大变 革。根据中国民航局的数据预测，到2025年中国低空经济市场规模将达到1.5万亿元，到2035年有望达 到3.5万亿元，eVTOL即将进入大规模量产阶段。 署名：永赢通用航空ETF基金经理刘庭宇 全球科技领域的博弈可能会持续进行，低空经济是我国技术处于全球领先水平且可以实现全产业链国产 化的新质生产力方向，也是中美同时在推进的科技主线，后续有望受益于自主可控升级的需求。 近期军工板块再次活跃，一方面受东南亚和南亚国家计划采购中国军机及防空装备的消息提振， ...